Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
HIV Eradication: One Step Closer
Scientists Crack Integrase Inhibitor Mystery
Gilead Reports Success With Quad Pill and Boosting Drug
New Hope for HIV Eradication
Study: Demand for HIV Vaccine Will Depend on How Good It Is
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

October 2, 2009

New Technology Finds Meds That Might Flush Out Hidden HIV Reservoirs

Scientists have successfully devised a method to find drugs that can flush out the hidden HIV that evades antiretroviral (ARV) drugs and makes viral eradication impossible, according to a study published in the Journal of Clinical Investigation and reported by Bloomberg News. So far, a compound called 5HN, which is derived from the black walnut tree, works best at coaxing out the latent reservoirs.

Researchers once hoped that ARV therapy would be potent enough to drive HIV to extinction, but they soon learned that the virus is able to survive by hiding out in resting CD4 cells. When people stop taking the drugs, the virus comes roaring back.

A number of attempts have been made to provoke these resting cells into activity and thus make the hidden virus accessible to ARVs, but all so far have failed.

Robert Siliciano, MD, PhD, from Johns Hopkins University in Baltimore and his colleagues now report they have developed a cell-based method for testing compounds that can activate resting CD4 cells. They’ve already tested 2.400 compounds and hope that the technology will ultimately lead to the successful development of an activating drug that, in combination with ARV therapy, will finally be able to eradicate HIV.

AIDSmeds will release an in-depth web exclusive in the coming weeks about this promising news.

Search: HIV reservoir, latent cells, resting cells, CD4 cells, Robert Siliciano


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 6 (of 6 total)    

EMMA.UMENYI, LAGOS, 2009-11-01 13:32:40
IT IS A VERY GOOD NEWS,AND SHOULD BE FELLOWED UP URGENTLY FOR MANY PEOPLE ON ARV FOR A VERY LONG TIME WHERE DEVELOPING RESISTANT DUE TO NOT KEEPING TO THE TIME AND VERY FADE UP OF USE MED, FOR A VERY LONG TIME.

pablitomon, Newport Bech, CA, 2009-10-13 17:23:02
THIS IS THE MOST EXITING news I've heard in a long time. I think we ought to throw ALL our effort in this direction. We need a BIG campoaign to rally up support, donations and public awareness of this. What are we waiting for? Let's do this!

Marcos, São Paulo, 2009-10-06 23:04:15
There are mso any good news popping up around and lately that make us smile in hope. At least one of those must result in an effective path of cure soon...Don´t you think?

Steve, Morristown, 2009-10-06 16:49:07
Reminds me of Mel Brooks' 'High Anxiety,' when the bellhop lifts the doc's suitcase and says, "I got it, I got it... I ain't got it." Yet, as is the case here. But this IS very encouraging (as well as its obvious importance in completely eradicating the virus), and between this and the ongoing vaccine trials, there's good news for everyone for a change, whether they are positive or not. Please, sir, I'd like some more (good news, that is!)

Matt, San Diego, 2009-10-06 09:33:20
This article is interesting from a zoopharmacognostical perspective because chimpanzees used walnuts or nuts in the walnut family as tools. It will be interesting to see what happens.

Barry, , 2009-10-04 23:47:38
Does anyone have any early reports from UPenn HIV trial initiated in Feb 2009? clinicaltrials.gov identifier. NCT00842634. A second PH I trial has been approved by FDA. Sangamo Biosciences to run second trial. It seems like a long time for the first trial to not have some early results.

comments 1 - 6 (of 6 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009


16th Conference on Retroviruses and Opportunistic Infections (CROI 2009)
Montréal, Canada
February 8-11, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy